American Century Companies
BBNX

American Century Companies’s Beta Bionics BBNX Stock Holding History

American Century Companies’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$240K Buy
23,904
+11,880
+99% +$176K ﹤0.01% 2672
2025
Q4 		$366K Buy
+12,024
New +$321K ﹤0.01% 2589

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies's BBNX Position: Q1 2026 in Review

American Century Companies increased its Beta Bionics (BBNX) stake by 99% in Q1 2026, buying an estimated $176K and bringing the position to 23,904 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #2672.

American Century Companies first reported a position in BBNX in Q4 2025 and has held it in 2 quarters since. The position peaked at $366K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • American Century Companies held 23,904 shares of Beta Bionics worth $240K as of Q1 2026.
  • American Century Companies bought 11,880 Beta Bionics shares in Q1 2026, an estimated $176K.
  • Beta Bionics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2672 holding.
  • American Century Companies first reported a position in Beta Bionics in Q4 2025 and has held it in 2 quarters since.
  • American Century Companies's Beta Bionics position peaked at $366K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.